1: Nichols N, Bras JM, Hernandez DG, Jansen IE, Lesage S, Lubbe S, Singleton AB;
International Parkinson's Disease Genomics Consortium.. EIF4G1 mutations do not
cause Parkinson's disease. Neurobiol Aging. 2015 Aug;36(8):2444.e1-4. doi:
10.1016/j.neurobiolaging.2015.04.017. Epub 2015 May 9. PubMed PMID: 26022768;
PubMed Central PMCID: PMC4464946.
2: Deng H, Wu Y, Jankovic J. The EIF4G1 gene and Parkinson's disease. Acta Neurol
Scand. 2015 Aug;132(2):73-8. doi: 10.1111/ane.12397. Epub 2015 Mar 13. Review.
PubMed PMID: 25765080.
3: Huttenlocher J, Krüger R, Capetian P, Lohmann K, Brockmann K, Csoti I, Klein
C, Berg D, Gasser T, Bonin M, Riess O, Bauer P. EIF4G1 is neither a strong nor a
common risk factor for Parkinson's disease: evidence from large European cohorts.
J Med Genet. 2015 Jan;52(1):37-41. doi: 10.1136/jmedgenet-2014-102570. Epub 2014
Nov 3. PubMed PMID: 25368108.
4: Akabayov SR, Akabayov B, Wagner G. Human translation initiation factor eIF4G1
possesses a low-affinity ATP binding site facing the ATP-binding cleft of eIF4A
in the eIF4G/eIF4A complex. Biochemistry. 2014 Oct 21;53(41):6422-5. doi:
10.1021/bi500600m. Epub 2014 Oct 8. PubMed PMID: 25255371; PubMed Central PMCID:
PMC4204880.
5: Attar-Schneider O, Drucker L, Zismanov V, Tartakover-Matalon S, Lishner M.
Targeting eIF4GI translation initiation factor affords an attractive therapeutic
strategy in multiple myeloma. Cell Signal. 2014 Sep;26(9):1878-87. doi:
10.1016/j.cellsig.2014.05.005. Epub 2014 May 9. PubMed PMID: 24815186.
6: Nishioka K, Funayama M, Vilariño-Güell C, Ogaki K, Li Y, Sasaki R, Kokubo Y,
Kuzuhara S, Kachergus JM, Cobb SA, Takahashi H, Mizuno Y, Farrer MJ, Ross OA,
Hattori N. EIF4G1 gene mutations are not a common cause of Parkinson's disease in
the Japanese population. Parkinsonism Relat Disord. 2014 Jun;20(6):659-61. doi:
10.1016/j.parkreldis.2014.03.004. Epub 2014 Mar 18. PubMed PMID: 24704100; PubMed
Central PMCID: PMC4034257.
7: Blanckenberg J, Ntsapi C, Carr JA, Bardien S. EIF4G1 R1205H and VPS35 D620N
mutations are rare in Parkinson's disease from South Africa. Neurobiol Aging.
2014 Feb;35(2):445.e1-3. doi: 10.1016/j.neurobiolaging.2013.08.023. Epub 2013 Sep
27. PubMed PMID: 24080171.
8: Li K, Tang BS, Guo JF, Lou MX, Lv ZY, Liu ZH, Tian Y, Song CY, Xia K, Yan XX.
Analysis of EIF4G1 in ethnic Chinese. BMC Neurol. 2013 Apr 26;13:38. doi:
10.1186/1471-2377-13-38. PubMed PMID: 23617574; PubMed Central PMCID: PMC3663786.
9: Yuan L, Song Z, Xu H, Gu S, Zhu A, Gong L, Zhao Y, Deng H. EIF4G1 Ala502Val
and Arg1205His variants in Chinese patients with Parkinson disease. Neurosci
Lett. 2013 May 24;543:69-71. doi: 10.1016/j.neulet.2013.02.056. Epub 2013 Apr 2.
PubMed PMID: 23562511.
10: Siitonen A, Majounie E, Federoff M, Ding J, Majamaa K, Singleton AB.
Mutations in EIF4G1 are not a common cause of Parkinson's disease. Eur J Neurol.
2013 Apr;20(4):e59. doi: 10.1111/ene.12051. PubMed PMID: 23490116.
11: Dobrikov MI, Dobrikova EY, Gromeier M. Dynamic regulation of the translation
initiation helicase complex by mitogenic signal transduction to eukaryotic
translation initiation factor 4G. Mol Cell Biol. 2013 Mar;33(5):937-46. doi:
10.1128/MCB.01441-12. Epub 2012 Dec 21. PubMed PMID: 23263986; PubMed Central
PMCID: PMC3623071.
12: Fujioka S, Sundal C, Strongosky AJ, Castanedes MC, Rademakers R, Ross OA,
Vilariño-Güell C, Farrer MJ, Wszolek ZK, Dickson DW. Sequence variants in
eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with
Lewy body dementia. Acta Neuropathol. 2013 Mar;125(3):425-38. doi:
10.1007/s00401-012-1059-4. Epub 2012 Nov 4. PubMed PMID: 23124435; PubMed Central
PMCID: PMC3580022.
13: Badura M, Braunstein S, Zavadil J, Schneider RJ. DNA damage and eIF4G1 in
breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc
Natl Acad Sci U S A. 2012 Nov 13;109(46):18767-72. doi: 10.1073/pnas.1203853109.
Epub 2012 Oct 29. PubMed PMID: 23112151; PubMed Central PMCID: PMC3503184.
14: Zhao Y, Ho P, Prakash KM, Foo JN, Liu JJ, Au WL, Tan LC, Tan EK. Analysis of
EIF4G1 in Parkinson's disease among Asians. Neurobiol Aging. 2013
Apr;34(4):1311.e5-6. doi: 10.1016/j.neurobiolaging.2012.09.003. Epub 2012 Oct 23.
PubMed PMID: 23092605.
15: Kumar KR, Lohmann K, Klein C. Genetics of Parkinson disease and other
movement disorders. Curr Opin Neurol. 2012 Aug;25(4):466-74. doi:
10.1097/WCO.0b013e3283547627. Review. PubMed PMID: 22772876.
16: Schulte EC, Mollenhauer B, Zimprich A, Bereznai B, Lichtner P, Haubenberger
D, Pirker W, Brücke T, Molnar MJ, Peters A, Gieger C, Trenkwalder C, Winkelmann
J. Variants in eukaryotic translation initiation factor 4G1 in sporadic
Parkinson's disease. Neurogenetics. 2012 Aug;13(3):281-5. doi:
10.1007/s10048-012-0334-9. Epub 2012 Jun 16. PubMed PMID: 22707335.
17: Lesage S, Condroyer C, Klebe S, Lohmann E, Durif F, Damier P, Tison F, Anheim
M, Honoré A, Viallet F, Bonnet AM, Ouvrard-Hernandez AM, Vidailhet M, Durr A,
Brice A; French Parkinson's Disease Genetics Study Group.. EIF4G1 in familial
Parkinson's disease: pathogenic mutations or rare benign variants? Neurobiol
Aging. 2012 Sep;33(9):2233.e1-2233.e5. doi: 10.1016/j.neurobiolaging.2012.05.006.
Epub 2012 Jun 1. PubMed PMID: 22658323.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Human eIF4G Recombinant Protein” Cancel reply
Reviews
There are no reviews yet.